When to Initiate Weight Loss Medications in the NAFLD Population

When to Initiate Weight Loss Medications in the NAFLD Population

Nonalcoholic fatty liver disease (NAFLD) is characterized by histological evidence of hepatic steatosis, lobular inflammation, ballooning degeneration and hepatic fibrosis in the absence of significant alcohol use and other known causes of chronic liver diseases. NAFLD is subdivided into nonalcoholi...

Full description

Bibliographic Details
Main Authors: Eric R. Yoo, Sandy Sallam, Brandon J. Perumpail, Umair Iqbal, Neha D. Shah, Waiyee Kwong, George Cholankeril, Donghee Kim, Aijaz Ahmed
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:Diseases
Subjects:
NAFLD
NAFL
NASH
weight loss medication
weight loss
nutrition
Online Access:http://www.mdpi.com/2079-9721/6/4/91

Internet

http://www.mdpi.com/2079-9721/6/4/91

Similar Items